Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study to Assess the Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine

NCT01072799 is registered in ClinicalTrials.gov with Novavax as lead sponsor.

NCT NCT01072799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01072799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study to Assess the Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine
Lead sponsor
Novavax
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
March 31, 2012
Enrollment
4,560 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

seasonal influenza